The Urology clinical research program has many ongoing translational molecular oncology studies involving various cancer types: prostate, bladder and kidney cancer.
These studies include assessing patients’ primary metastatic site and the draining lymph nodes. One of our major prostate cancer studies is examining the sentinel lymph node of multi-focal cancer patients using next generation sequencing. We also develop cfNA assays from blood and urine specimens.
